US 10071945
Nuclear receptor modulators and their use for the treatment and prevention of cancer
granted A61KA61K31/12A61K31/275
Quick answer
US patent 10071945 (Nuclear receptor modulators and their use for the treatment and prevention of cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/12, A61K31/275, A61K45/06, A61P